News & Updates

Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.

Findings from the ACHIEVE* study suggest that older adults who are at increased risk for cognitive decline and dementia and who have hearing loss may benefit the most from hearing intervention within 3 years.

Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.

Essential workers, particularly at a Singapore hospital, have endured such a heavy burden during the COVID-19 pandemic, exposing themselves to risks of infections while putting up with increased workloads and workplace stress, longer hours in uncomfortable working conditions, as well as public stigmatization, results of a recent study show.

A retrospective study combining ex vivo and in vitro assays showed an independent association between COVID-19 and the onset of hyperglycaemia.